CYTOKINES IN ACUTE MYOCARDIAL-INFARCTION - SELECTIVE INCREASE IN CIRCULATING TUMOR-NECROSIS-FACTOR, ITS SOLUBLE RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:38
作者
LATINI, R
BIANCHI, M
CORREALE, E
DINARELLO, CA
FANTUZZI, G
FRESCO, C
MAGGIONI, AP
MENGOZZI, M
ROMANO, S
SHAPIRO, L
SIRONI, M
TOGNONI, G
TURATO, R
GHEZZI, P
机构
[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[2] TUFTS UNIV,NEW ENGLAND MED CTR,DIV GEOG MED & INFECT DIS,BOSTON,MA
[3] CASERTA HOSP,DIV CARDIOL,CASERTA,ITALY
[4] UDINE HOSP,DIV CARDIOL,UDINE,ITALY
[5] MAGENTA HOSP,DIV CARDIOL,MAGENTA,ITALY
关键词
MYOCARDIAL INFARCTION; CYTOKINES; TUMOR NECROSIS FACTOR; INTERLEUKIN-1;
D O I
10.1097/00005344-199401000-00026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cytokines play a pathogenetic role in a variety of infective and inflammatory diseases. In the present study, we had two objectives: (a) to define the kinetics of tumor necrosis factor (TNF) in plasma after acute myocardial infarction (AMI) in patients treated with early thrombolysis, and (b) to measure other cytokines, interleukin-l (IL-1) and TNF receptor antagonists, in plasma. TNF-alpha, but not IL-1 beta or IL-8, was present in plasma of 6 of 7 patients with severe AMI (Killip class 3 or 4). No TNF (<50 pg/ml) was detected in a group of 11 patients with uncomplicated myocardial infarction (Killip class 1) or in control patients without AMI. Soluble TNF receptor type I and IL-1 receptor antagonist (IL-1Ra) were also significantly increased in the group with severe AMI compared with those with uncomplicated AMI. Circulating TNF is increased only in AMI complicated by heart failure at hospital admission. This finding may have diagnostic and therapeutic relevance.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 27 条
[1]  
AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[3]   ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN THE PATHOPHYSIOLOGIC ALTERATIONS AFTER HEPATIC ISCHEMIA REPERFUSION INJURY IN THE RAT [J].
COLLETTI, LM ;
REMICK, DG ;
BURTCH, GD ;
KUNKEL, SL ;
STRIETER, RM ;
CAMPBELL, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1936-1943
[4]  
COPE AP, 1992, EUR CYTOKINE NETW, V3, P257
[5]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[6]  
DUBOIS C, 1989, J IMMUNOL, V143, P964
[7]   TUMOR-NECROSIS-FACTOR-ALPHA PRETREATMENT IS PROTECTIVE IN A RAT MODEL OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY [J].
EDDY, LJ ;
GOEDDEL, DV ;
WONG, GHW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1056-1059
[8]  
ENGELMANN H, 1989, J BIOL CHEM, V264, P11974
[9]   INFLAMMATION IN THE COURSE OF EARLY MYOCARDIAL-ISCHEMIA [J].
ENTMAN, ML ;
MICHAEL, L ;
ROSSEN, RD ;
DREYER, WJ ;
ANDERSON, DC ;
TAYLOR, AA ;
SMITH, CW .
FASEB JOURNAL, 1991, 5 (11) :2529-2537
[10]   HYPOXIA INCREASES PRODUCTION OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR BY HUMAN MONONUCLEAR-CELLS [J].
GHEZZI, P ;
DINARELLO, CA ;
BIANCHI, M ;
ROSANDICH, ME ;
REPINE, JE ;
WHITE, CW .
CYTOKINE, 1991, 3 (03) :189-194